LEWISVILLE, Texas, Sept. 30, 2019 /PRNewswire-PRWeb/ -- AppleGate Recovery, a BayMark Health Services Company, announced
"AppleGate Recovery was founded with the goal of providing patients comprehensive, individualized treatment for opioid addiction. As the opioid crisis continues unabated there has never been a greater need," said Mike Saul, Division President of AppleGate Recovery. "Time and time again we have seen that when patients are provided a combination of medication, counseling and other support services, they can recover. Now the focus is on bringing treatment options to areas of the community that are currently underserved, helping patients identify what recovery looks like for them and how we can help them get there."
AppleGate Recovery medical providers utilize buprenorphine and buprenorphine compounds, also known by the brand names Suboxone® Zubsolv®, Bunavail® to help patients control withdrawal symptoms and cravings for opioids. In addition to medication services, AppleGate provides in house counseling, lab services and case management. This proven treatment model addresses both the physical symptoms and the mental and emotional aspects of addiction.
Chief Executive Officer David K. White, Ph.D. shared, "BayMark, through our various treatment brands, focuses on the goal of improving access to the right treatment type for each patient we serve. Our expansion in Louisiana is a part of that focus, and we'll continue to work to address areas of the state in need of meaningful, effective treatment options. In addition to office-based outpatient treatment, BayMark offers more structured MAT with methadone, as well as both inpatient and outpatient withdrawal management options in Louisiana. Regardless of where our patients are at in their journey, BayMark can offer help and hope."
Located at 905 East 7th Avenue, Suite 7, Oakdale LA, AppleGate is now accepting new patients. Call 318.300.4254 to make an appointment or for more information about treatment visit: http://www.AppleGateRecovery.com.
About BayMark Health Services:
BayMark Health Services provides medication-assisted treatment to more than 53,000 patients in recovery from substance use disorder across the United States and Ontario, Canada. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances. The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.
SOURCE BayMark Health Services